0000886163-23-000051.txt : 20230814
0000886163-23-000051.hdr.sgml : 20230814
20230814162056
ACCESSION NUMBER: 0000886163-23-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reardon Andrew
CENTRAL INDEX KEY: 0001950232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 231170625
MAIL ADDRESS:
STREET 1: C/O LIGAND PHARMACEUTICALS INCORPORATED
STREET 2: 3911 SORRENTO VALLEY BLVD, SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-08-10
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001950232
Reardon Andrew
3911 SORRENTO VALLEY, SUITE 110
SAN DIEGO
CA
92121
0
1
0
0
CHIEF LEGAL OFFICER &
0
Common Stock
2023-08-10
4
F
0
897
68.73
D
15411
D
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
/s/ Andrew Reardon
2023-08-14